Mycoplasma hominis can be isolated from the urogenital tracts of up to 40% of asymptomatic males and females. However, it is a proven cause of pelvic inflammatory disease, postpartum septicemia and endometritis, clinical amnionitis, and pyelonephritis (4) . It is also a major cause of pneumonia and central nervous system infections in newborn infants (for a review, see reference 5). Furthermore, M. hominis is increasingly being recognized as a common cause of septicemia, arthritis, surgical wound infections, and peritonitis in immunocompromised patients (16, 17) .
Identification of clinical isolates and serodiagnosis of M. hominis infections are complicated by the heterogeneity within the species. Remarkable differences between strains of M. hominis have been documented by serology (3, 14) , DNA-DNA hybridization (7), comparison of protein patterns (1) , analysis of DNA restriction enzyme cleavage patterns (7, 8) , and genome mapping (13) .
Heterogeneity has also been documented in DNA hybridization studies using rRNA genes as probes to detect restriction fragment length polymorphisms (9) . Although most of the restriction fragment length polymorphisms could be explained by variations in restriction enzyme cleavage sites outside the rRNA cistrons, some were also observed within these cistrons. The 16S rRNA gene sequences of more than 40 different mycoplasma species, including the type strain, PG21, of M. hominis, have been determined, providing the basis for a phylogenetic study of these organisms (24) . In addition, this information allows the identification of specific sequences that can be used to design primers for DNA amplification by polymerase chain reaction (PCR) for improved detection of mycoplasmas in clinical specimens. (14) .
The source of the serotype strains of U. urealyticum was previously described (12) , and the other strains of mycoplasmas were kindly provided by J. G. Tully (National Institute of Allergy and Infectious Diseases, Frederick, Md.).
A total of 51 clinical isolates from the urethras of 10 males with nongonococcal urethritis and from the cervixes of 41 females with nongonococcal cervicitis were evaluated. Identification of the isolates as M. hominis was based on growth and metabolic characteristics and on positive identification by immunoblotting with monoclonal antibodies which were shown to react with M. hominis but with no other mycoplasma species known to occur in humans. The specificity of these immunological reagents was assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) VOL. 31, 1993 amplification was performed in a total volume of 50 ,ul, as described by Saiki et al. (18) . Lysates to be analyzed (5 ,ul) were always added last. A positive control (diluted lysate of M. hominis corresponding to 100 color-changing units [CCU] ) and a negative control (sterile water) were included in each PCR experiment. The thermal profile involved 40 cycles of denaturation at 95°C for 25 s, primer annealing at 62°C for 60 s, and extension at 72°C for 60 s. Following PCR amplification, aliquots (20 ,ul) were analyzed by electrophoresis through a 2% agarose gel, and DNA was visualized by UV fluorescence after ethidium bromide staining. Southern transfer of DNA onto nylon membrane and 5'-end labeling of hybridization probes with T4 polynucleotide kinase were done as previously described (2) .
For evaluation of the sensitivity of PCR detection, exponential cultures of M. hominis 10, PG21T, 93, and 183 were centrifuged (12,000 x g, 20 min, 4°C). The supernatant was discarded, and the bacterial pellet was lysed as described above. Lysates were subsequently serially diluted in the lysis solution without proteinase K, and the dilutions were evaluated by PCR. The concentration of M. hominis organisms in the cultures was determined by establishing the number of CFU present on SP-4 agar plates and the number of CCU in SPA broth (21) . The sensitivity was also evaluated with purified DNA from M. hominis, and the concentrations of DNA stock solutions were determined by the spectrophotometric method (19 PCR primers for the specific amplification of a 334-bp DNA fragment of the 16S rRNA gene of M. hominis were chosen after the two M. hominis sequences were aligned with the published homologous sequences from different mycoplasmas. They were chosen in regions that are variable among other mycoplasma species (and a fortiori among other bacteria) but identical for the two strains of M. hybridization with the internal probe RNAH3 was used to evaluate the specificity of the amplification after electrophoresis.
PCR specificity was evaluated by using multiple strains of the 13 mycoplasma species most commonly isolated from humans and DNAs from human epithelial and peripheral blood mononuclear cells. PCR detection with primers RNAH1 and RNAH2 was highly specific, as it consistently allowed the amplification of a product with the expected length (334 bp) with the seven reference strains of M. hominis (Fig. 2) but not with heterologous species or with DNA from humans. Nonspecific amplification was obtained with strains of M. salivanum. However, the amplified DNA fragment was larger than that obtained with M. hominis (433 bp versus 334 bp). Analysis of the restriction pattern of this DNA fragment after digestion with HinduII, RsaI, and TaqI indicated that this amplicon is part of the 16S rRNA gene of M. salivarium, although only a weak homology between RNAH2 and the published sequence for this gene was found. However, only the specific amplified product obtained with M. hominis was shown to be homologous to the internal probe RNAH3 by Southern hybridization (Fig. 2B) .
The specificity of PCR detection was also evaluated by using 51 clinical isolates of M. hominis which had been artificially passaged only a few times and which were from diverse geographic locations. All of them were positive by this assay.
The sensitivity of the PCR assay was determined with lysates of four different reference strains of M. hominis: for strain 10, 0.07 CFU or 0.05 CCU; for strain PG21T, 0.4 CFU or S CCU; for strain 93, 0.2 CFU or 0.5 CCU; and for strain 183, 0.13 CFU or 0.05 CCU. The sensitivity of the PCR assay was also evaluated with purified DNAs from three M. hominis strains: 10, 93, and 132. The limit of detection of the PCR assay was between 10 and 15 fg of M. hominis DNA; results obtained with strain 93 are shown in Fig. 3 . Since the genome size of this mycoplasma is about 800 kbp (13), 10 fg is equivalent to the amount of DNA derived from about 12 organisms.
On the basis of DNA-DNA hybridization, genomic homology between strains PG21T and 183 of M. hominis was found to be only 55% (7); however, the differences between their 16S rDNA sequences are limited. This confirms the high degree of intraspecies conservation within this gene. How- 19) was a 123-bp DNA ladder (GIBCO BRL, Gaithersburg, Md.). RNAH3 was the probe used in panel B.
ever, 16S rDNA sequence identity can be found between two close but distinct species, as was recently described for the genus Bacillus (10) . Clearly, the two strains of M. hominis that were compared in this study belong to what has been called "the same rRNA species complex" (10), but the DNA-DNA hybridization data suggest that they could be relegated to different subspecies.
We have established a PCR assay for the detection of M. hominis using part of the 16S rDNA as a target. The assay was shown to be specific after evaluation of the 7 reference strains and 51 clinical isolates from different geographic sites. The cross-reaction obtained with M. salivarium can be easily differentiated because the size of the amplified fragment is different from that of the fragment obtained with M. hominis and does not hybridize with the internal probe (RNAH3). Under optimal conditions, the PCR assay consistently allowed the detection of less than 1 CFU or CCU from a culture of the four reference strains of M. hominis that were tested. This result is not surprising because DNA of both viable and nonviable mycoplasmas can be amplified, whereas only viable organisms will produce colonies on agar or grow in broth. In addition, M. hominis in culture can form clumps of cells that will also contribute to the higher sensitivity of PCR compared with culture. The limits of detection of this PCR assay (about 12 organisms) as determined with purified DNA are comparable to what was reported with other systems (11) . Because microbiological detection of M. hominis is costly, requires special expertise, and does not yield results until 2 to 5 days later (6) , this rapid PCR detection method should prove to be of considerable value in directly detecting this organism in clinical samples without prior cultivation.
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